Showing results (1-10 of 165) with videos related to

Sort By:
Pageof 17
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 2, 2008
Modelling placebo response in depression trials using a longitudinal model with informative dropoutRoberto Gomeni, Agnes Lavergne, Emilio Merlo-Pich
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 4, 2011
Trial Simulation to estimate Type I error when a population window enrichment strategy is used to improve efficiency of clinical trials in depressionRoberto Gomeni, Emilio Merlo-Pich
British Journal of Clinical Pharmacology|May 10, 2007
Bayesian modelling and ROC analysis to predict placebo responders using clinical score measured in the initial weeks of treatment in depression trialsRoberto Gomeni, Emilio Merlo-Pich
Current Opinion in Pharmacology|July 26, 2011
Understanding pharmacology in humans: Phase I and Phase II (data generation)Emilio Merlo Pich
Pharmacology, Biochemistry, and Behavior|June 22, 2002
Corticosterone administration to rat pups, but not maternal separation, affects sexual maturation and glucocorticoid receptor immunoreactivity in the testisGiuseppe Biagini, Emilio Merlo Pich
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 24, 2015
Pharmacological targeting of dopamine D3 receptors: Possible clinical applications of selective drugsEmilio Merlo Pich, Ginetta Collo
Frontiers in Neuroscience|March 5, 2014
Orexin 1 receptor antagonists in compulsive behavior and anxiety: possible therapeutic useEmilio Merlo Pich, Sergio Melotto
Chronic Stress (Thousand Oaks, Calif.)|May 23, 2020
Structural Plasticity Induced by Ketamine in Human Dopaminergic Neurons as Mechanism Relevant for Treatment-Resistant DepressionGinetta Collo, Laura Cavalleri, Emilio Merlo Pich
Handbook of Experimental Pharmacology|November 7, 2012
Biomarkers for antipsychotic therapiesEmilio Merlo Pich, Gabriel Vargas, Enrico Domenici
Neuroreport|December 27, 2018
Ketamine increases the expression of GluR1 and GluR2 α-amino-3-hydroxy-5-methy-4-isoxazole propionate receptor subunits in human dopaminergic neurons differentiated from induced pluripotent stem cellsGinetta Collo, Laura Cavalleri, Cristiano Chiamulera, et al.
Pageof 17